Different cancers can be divided into molecular subtypes based on their genetic and molecular profiles. These subtypes respond differently to treatments. For example:
HER2-positive breast cancer may respond well to targeted therapies like trastuzumab. Triple-negative breast cancer lacks targeted treatment options and is often treated with chemotherapy.
